David Natan

Director

 

David Natan has served as Director and Audit Committee Chair of Sunshine Biopharma, Inc. (NASDAQ: SBFM) since February 2022.

He currently serves as CEO of Natan & Associates, LLC., a consulting firm offering CFO services to public and private companies since 2007. From February 2010 to May 2020, Mr. Natan served as CEO of ForceField Energy, Inc. (OTCMKTS: FNRG), a company focused on LED lighting products. From February 2002 to November 2007, Mr. Natan served as CFO of PharmaNet Development Group, Inc., a drug development company, and, from June 1995 to February 2002, as CFO and VP of Global Technovations, Inc., a manufacturer and marketer of speaker components. Prior to that, Mr. Natan served in various roles with Deloitte & Touche LLP. From April 2020 through June 2023, Mr. Natan was Executive Vice President and Chief Financial Officer for Airborne Motorworks, Inc., Spokane, WA, a privately-held aerospace transportation company.

Mr. Natan currently serves as a member of the Board of Directors and Chair of the Audit Committee of NetBrands, Inc. (OTC: NBND), a distributor of snack products, since February 2021; and serves as a member of the Board of Directors and Chair of the Audit Committee of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a pharmaceutical company, since August 2022. Additionally, in November 2023, Mr. Natan was appointed to the Board of Directors and Audit Committee Chair of Minim, Inc. (NASDAQ: MINM).

Mr. Natan holds a B.A. in Economics from Boston University.